Solstein Capital’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.9K | Hold |
4,477
| – | – | 0.01% | 319 |
|
|
2025
Q1 | $9.63K | Hold |
4,477
| – | – | 0.01% | 239 |
|
|
2024
Q4 | $17.3K | Hold |
4,477
| – | – | 0.01% | 214 |
|
|
2024
Q3 | $29.3K | Hold |
4,477
| – | – | 0.02% | 179 |
|
|
2024
Q2 | $32.5K | Hold |
4,477
| – | – | 0.02% | 164 |
|
|
2024
Q1 | $34K | Hold |
4,477
| – | – | 0.02% | 161 |
|
|
2023
Q4 | $20.4K | Hold |
4,477
| – | – | 0.02% | 186 |
|
|
2023
Q3 | $17.7K | Hold |
4,477
| – | – | 0.02% | 190 |
|
|
2023
Q2 | $14K | Hold |
4,477
| – | – | 0.01% | 205 |
|
|
2023
Q1 | $20.3K | Hold |
4,477
| – | – | 0.02% | 164 |
|
|
2022
Q4 | $18.5K | Hold |
4,477
| – | – | 0.02% | 180 |
|
|
2022
Q3 | $14K | Hold |
4,477
| – | – | 0.01% | 211 |
|
|
2022
Q2 | $9K | Hold |
4,477
| – | – | 0.01% | 263 |
|
|
2022
Q1 | $18K | Hold |
4,477
| – | – | 0.01% | 256 |
|
|
2021
Q4 | $48K | Hold |
4,477
| – | – | 0.03% | 218 |
|
|
2021
Q3 | $52K | Hold |
4,477
| – | – | 0.03% | 226 |
|
|
2021
Q2 | $44K | Hold |
4,477
| – | – | 0.05% | 228 |
|
|
2021
Q1 | $65K | Buy |
+4,477
| New | +$65K | 0.09% | 192 |
|